Clin2
NCT07495410Possibly a fitEnrolling by invitation

Exercise training for Anderson-Fabry disease

Fabry Disease

Part of Brain & nervous system, Genetic & congenital, Heart & circulation, Hormones & metabolism clinical trials.

This study tests whether a supervised exercise and physiotherapy program can improve fitness, stamina, and daily life for people with Anderson-Fabry disease. It is designed for people who are medically stable and able to join a gentle, progressive training program.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
15 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have been diagnosed with Anderson-Fabry disease.
  • You are 18 years old or older.
  • You are being treated at one of the hospitals taking part in this study.
  • You are healthy enough to safely start an exercise and physical therapy program.
  • You can understand the study and agree to take part.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07235709Recruiting
Study of agalsidase alfa for heart inflammation in Fabry disease

This trial tests whether agalsidase alfa can reduce heart inflammation in people with Fabry disease who have heart problems. You may qualify if you have not had this treatment in the past year.

Seoul
NCT07187440Recruiting
Study of Fabry disease treatment in Chinese children and adults

This study tests an enzyme replacement therapy (agalsidase alfa) for Fabry disease in Chinese children and adults. It's an observational study that follows patients who receive the treatment as part of their regular care.

Hefei, Anhui
NCT06880250Enrolling by invitation
Enzyme therapy study for Fabry disease patients

This trial tests if enzyme replacement therapy works well and is safe for Fabry disease. It is for people who are already prescribed this treatment.

Astrakhan
NCT06806813Recruiting
Italian Fabry disease heart registry

This study is creating a registry of people with Fabry disease to better understand how it affects the heart. By joining, you help doctors learn more about the condition and improve care for future patients.

Chieti, Abruzzo/Chieti
NCT05629559Recruiting· Phase 1/Phase 2
Study drug 4D-310 for Fabry disease with heart problems

This Phase 1/2 study tests how safe and potentially effective 4D-310 is for adults with Fabry disease who have heart involvement. It may help people who can’t tolerate standard treatments like enzyme replacement therapy (ERT) or migalastat, or who still have disease progression.

Melbourne
NCT03362164Recruiting
Studying heart involvement in people with Fabry disease

This study looks at how the heart is affected in adults with Fabry disease. It may help doctors better understand heart-related changes in order to guide care.

Würzburg, Bavaria

Hear when a new Fabry Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.